Search Results - "Davineni, Phani"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions by Vivero, Marina, Davineni, Phani, Nardi, Valentina, Chan, John K. C., Sholl, Lynette M.

    Published in Modern pathology (01-04-2020)
    “…Metaplastic thymomas are rare biphasic thymic tumors that are characteristically well-circumscribed, confined to the thymus, and follow a benign to indolent…”
    Get full text
    Journal Article
  2. 2

    Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations by Siegmund, Stephanie E., Manning, Danielle K., Davineni, Phani K., Dong, Fei

    Published in Modern pathology (01-10-2022)
    “…Tumor purity, or the relative contribution of tumor cells out of all cells in a pathological specimen, influences mutation identification and clinical…”
    Get full text
    Journal Article
  3. 3

    Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? by Bale, Tejus A., Oviedo, Angelica, Kozakewich, Harry, Giannini, Caterina, Davineni, Phani K., Ligon, Keith, Alexandrescu, Sanda

    Published in Brain pathology (Zurich, Switzerland) (01-03-2018)
    “…Intracranial myxoid mesenchymal tumor harboring EWSR1 fusions with CREB family of genes was recently described, and it resembles the myxoid variant of…”
    Get full text
    Journal Article
  4. 4

    A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma by Dong, Fei, Davineni, Phani K, Howitt, Brooke E, Beck, Andrew H

    “…Mutational signatures have been identified by the broad sequencing of cancer genomes and reflect underlying processes of mutagenesis. The clinical application…”
    Get full text
    Journal Article
  5. 5

    Allelic Complexity of KMT2A Partial Tandem Duplications in Acute Myeloid Leukemia and Myelodysplastic Syndromes by Tsai, Harrison K., Gibson, Christopher J., Murdock, H. Moses, Davineni, Phani, Harris, Marian H., Wang, Eunice S., Gondek, Lukasz P., Kim, Annette S., Nardi, Valentina, Lindsley, R. Coleman

    Published in Blood advances (26-07-2022)
    “…KMT2A partial tandem duplication (KMT2A-PTD) is an adverse risk factor in AML and MDS, a potential therapeutic target, and an attractive marker of measurable…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12